195 related articles for article (PubMed ID: 7086136)
1. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
Murray HW; Masur H; Keithly JS
J Immunol; 1982 Jul; 129(1):344-50. PubMed ID: 7086136
[No Abstract] [Full Text] [Related]
2. Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes.
Murray HW
J Immunol; 1982 Jul; 129(1):351-7. PubMed ID: 6282967
[No Abstract] [Full Text] [Related]
3. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental visceral leishmaniasis with lymphokine encapsulated in liposomes.
Reed SG; Barral-Netto M; Inverso JA
J Immunol; 1984 Jun; 132(6):3116-9. PubMed ID: 6725947
[TBL] [Abstract][Full Text] [Related]
5. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
Hockmeyer WT; Walters D; Gore RW; Williams JS; Fortier AH; Nacy CA
J Immunol; 1984 Jun; 132(6):3120-5. PubMed ID: 6725948
[TBL] [Abstract][Full Text] [Related]
6. Importance of lymphokines in the control of multiplication and dispersion of Leishmania donovani within liver macrophages of resistant and susceptible mice.
Olivier M; Proulx C; Tanner CE
J Parasitol; 1989 Oct; 75(5):720-7. PubMed ID: 2529362
[TBL] [Abstract][Full Text] [Related]
7. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of intracellular killing of parasitic protozoa by macrophages.
Mauel J
Immunobiology; 1982 Apr; 161(3-4):392-400. PubMed ID: 6807834
[TBL] [Abstract][Full Text] [Related]
9. Recognition of Leishmania donovani antigens by murine T lymphocyte lines and clones. Species cross-reactivity, functional correlates of cell-mediated immunity, and antigen characterization.
Sheppard HW; Scott PA; Dwyer DM
J Immunol; 1983 Sep; 131(3):1496-503. PubMed ID: 6193191
[TBL] [Abstract][Full Text] [Related]
10. [Observation on susceptibilities and immune responses of four strains of mice to the infection of a Leishmania donovani Chinese strain].
Yi TL; Hu XS; Feng RY
Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):122-6. PubMed ID: 3837361
[No Abstract] [Full Text] [Related]
11. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
Mazumdar T; Anam K; Ali N
Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
13. rIL-2-stimulated splenocytes reactivate the NO2-producing ability of macrophages infected by Leishmania donovani.
Eslami Z; Tanner CE
Immunopharmacol Immunotoxicol; 2000 Aug; 22(3):465-87. PubMed ID: 10946826
[TBL] [Abstract][Full Text] [Related]
14. A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages.
Haidaris CG; Bonventre PF
J Immunol; 1982 Aug; 129(2):850-5. PubMed ID: 6282971
[TBL] [Abstract][Full Text] [Related]
15. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
[TBL] [Abstract][Full Text] [Related]
16. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction.
Moore KJ; Labrecque S; Matlashewski G
J Immunol; 1993 May; 150(10):4457-65. PubMed ID: 8482844
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce antimicrobial activities against amastigotes.
Oster CN; Nacy CA
J Immunol; 1984 Mar; 132(3):1494-500. PubMed ID: 6363544
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunization with lipid associated polysaccharide antigen and anti CD-2 antibodies on class II MHC expression and cellular immune response in BALB/C mice infected with Leishmania donovani.
Bimal S; Bagchi AK; Das V; Sinha PK; Lal CS; Ranjan A; Gupta AK; Kar SK
Indian J Exp Biol; 2001 Sep; 39(9):878-82. PubMed ID: 11831368
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
20. Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.
Rezai HR; Farrell J; Soulsby EL
Clin Exp Immunol; 1980 Jun; 40(3):508-14. PubMed ID: 6968259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
